In a story about technicians and medical professionals being enlisted to administer COVID-19 vaccines, Mark Miller, D.M.D., says: “A lot of people see the dentist more often than their doctor, so we have an opportunity to vaccinate a lot of people.”
Kevin Winthrop, M.D., comments on a new study suggesting patients being treated with certain therapies for chronic inflammatory diseases have reduced –- but still sufficient –- immune responses to COVID-19 vaccines: “It’s hard to extricate that from the effect of the underlying disease.”
In a story about excess mortality among people with Cushing’s syndrome compared with the overall population, Maria Fleseriu, M.D., says: “We definitely need a multidisciplinary approach to address complications and etiologic treatment as well as the reduced long-term quality of life in patients with Cushing’s syndrome.”
Staff editorial cites remarkable achievement of mass vaccination sites, a massive start-from-scratch public health initiative led by OHSU and other health systems: “As we reported at the PDX mass vaccination site, the mood was joyous, the energy high, the gratitude apparent. Not perfect, for sure. But trending well.”
Photo shows OHSU vaccination site with a story about a Kaiser Family Foundation study that suggests the U.S. may be reaching a “tipping point” in the next two to four weeks when vaccine supply will outpace demand.